600664.SH
Harbin Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 8.22
+0.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 31.25x
- P/E 2027E
- 26.79x
- P/E 2028E
- 23.44x
- P/S forward
- 4.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- 57.25x
- PEG TTM
- —
- Price / book
- 3.53x
- Price / sales
- 1.18x
- Price / cash flow
- 26.30x
Enterprise value
- Enterprise value
- CNY 17.6B
- EV / sales
- 1.10x
- EV / EBITDA
- 21.41x
- EV / EBIT
- 33.64x
- Market cap
- CNY 20.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026